Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS
· Delayed Price · Currency is USD
22.60
-0.08 (-0.35%)
Apr 1, 2025, 3:59 PM EST
Chugai Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 74,810 | 73,254 | 62,351 | 42,013 | 53,339 | 87,648 | Upgrade
|
| Market Cap Growth | 17.49% | 17.49% | 48.41% | -21.23% | -39.15% | 72.61% | Upgrade
|
| Enterprise Value | 68,137 | 67,877 | 57,961 | 37,878 | 49,894 | 84,559 | Upgrade
|
| Last Close Price | 22.74 | 21.97 | 18.85 | 12.67 | 16.36 | 26.60 | Upgrade
|
| PE Ratio | 30.37 | 29.74 | 27.00 | 14.80 | 20.27 | 42.13 | Upgrade
|
| PS Ratio | 9.84 | 9.84 | 7.91 | 4.40 | 6.14 | 11.50 | Upgrade
|
| PB Ratio | 6.06 | 6.06 | 5.41 | 3.89 | 5.17 | 9.23 | Upgrade
|
| P/TBV Ratio | 6.11 | 6.11 | 5.47 | 3.96 | 5.27 | 9.46 | Upgrade
|
| P/FCF Ratio | 29.03 | 29.03 | 26.01 | 30.53 | 28.74 | 61.12 | Upgrade
|
| P/OCF Ratio | 25.73 | 25.73 | 21.44 | 22.70 | 21.96 | 44.12 | Upgrade
|
| EV/Sales Ratio | 8.69 | 9.12 | 7.35 | 3.97 | 5.75 | 11.09 | Upgrade
|
| EV/EBITDA Ratio | 17.73 | 18.77 | 17.35 | 8.85 | 12.69 | 26.32 | Upgrade
|
| EV/EBIT Ratio | 18.77 | 19.69 | 18.60 | 9.37 | 13.62 | 28.97 | Upgrade
|
| EV/FCF Ratio | 27.01 | 26.90 | 24.17 | 27.52 | 26.89 | 58.97 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.03 | 0.02 | 0.04 | 0.03 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.04 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.59 | 0.74 | 0.72 | 0.69 | Upgrade
|
| Inventory Turnover | 1.32 | 1.32 | 1.46 | 1.90 | 1.72 | 1.55 | Upgrade
|
| Quick Ratio | 4.59 | 4.59 | 3.68 | 2.40 | 2.53 | 2.68 | Upgrade
|
| Current Ratio | 5.53 | 5.53 | 4.74 | 3.15 | 3.25 | 3.54 | Upgrade
|
| Return on Equity (ROE) | 21.96% | 21.96% | 21.34% | 28.67% | 27.95% | 23.42% | Upgrade
|
| Return on Assets (ROA) | 16.36% | 16.36% | 14.44% | 19.56% | 19.01% | 16.41% | Upgrade
|
| Return on Capital (ROIC) | 19.21% | 19.21% | 17.84% | 25.23% | 24.02% | 20.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.30% | 28.30% | 26.70% | 36.90% | 34.80% | 30.10% | Upgrade
|
| Earnings Yield | 3.29% | 3.36% | 3.70% | 6.76% | 4.93% | 2.37% | Upgrade
|
| FCF Yield | 3.37% | 3.44% | 3.84% | 3.28% | 3.48% | 1.64% | Upgrade
|
| Dividend Yield | 2.71% | 2.84% | 3.01% | 4.67% | 4.04% | 2.00% | Upgrade
|
| Payout Ratio | 34.40% | 34.40% | 40.43% | 36.91% | 32.56% | 42.58% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | -0.03% | Upgrade
|
| Total Shareholder Return | 2.71% | 2.83% | 3.00% | 4.66% | 4.03% | 1.97% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.